Serum protein signature may improve detection of ductal carcinoma in situ of the breast (Q84779952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Serum protein signature may improve detection of ductal carcinoma in situ of the breast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Pierre-Jean Lamy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ben Allal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gilles Favre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Alain Mangé

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

P Rouanet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

T Maudelonde

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

26 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

550-560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19855429%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2009.341

11 February 2020

exact match

0 references

cites work

Reproducibility in protein profiling by MALDI-TOF mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Ascitic complement system in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Selection of highly metastatic rat MTLn2 mammary adenocarcinoma cell variants using in vitro growth response to transferrin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Platelet-associated PF-4 as a biomarker of early tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Contribution of oncoproteomics to cancer biomarker discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Screening for breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

A role for biomarkers in the screening and diagnosis of breast cancer in younger women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Mining the plasma proteome for cancer biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

31 March 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

The biochemical modification of the erythrocyte membranes from women with ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Characterization of serum biomarkers for detection of early stage ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

mROC: a computer program for combining tumour markers in predicting disease states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Ductal carcinoma in situ: state of the science and roadmap to advance the field

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Biomarkers for early detection of breast cancer: what, when, and where?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Comprehensive proteomic analysis of the human milk proteome: contribution of protein fractionation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Serum biomarkers for detection of breast cancers: A prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

BI-RADS categorization as a predictor of malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

TM4: a free, open-source system for microarray data management and analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Structure and biology of complement protein C3, a connecting link between innate and acquired immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Clinical proteomics and mass spectrometry profiling for cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Mass spectrometry: uncovering the cancer proteome for diagnostics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341

Identification of serum biomarkers for colon cancer by proteomic analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.341